Minapharm Pharmaceuticals (MIPH) trades on the Egyptian Exchange (EGX) in the Health Technology sector. Last updated 10 Sept 2026, 21:08 (Cairo time). EGX sector classification: Health Care & Pharmaceuticals.
What is Minapharm Pharmaceuticals’s share price today? MIPH last traded at EGP 810.98 (+1.62% on the day), for a market value of EGP 9.14 billion and a dividend yield of 0.31%. Its 52-week range is EGP 250 to 824.92.
Total return based on EGX closing prices. Past performance does not indicate future results.
MINAPHARM Pharmaceuticals produces medicines, chemicals, medical and dental supplies, cosmetics, veterinary and herbal medicines, and dietary supplements in Egypt and internationally.It operates through Biological Production, Drug Production, and Other Pharmaceuticals segments. The company provides its products for the treatment of acne, alopecia, analgesics and anti-inflammation, atopic dermatitis, autoimmune disease, bone health, cardiovascular, cerebral insufficiency, diabetic neuropathy and retinopathy, dyslipidemia, gastroenterology and hepatology, glaucoma, hematoma and thrombosis, hemorrhoids, haemostasis, immuno-stimulants and immunomodulatory, and infertility, as well as for iron deficiency anemia, labour induction, menopause, nausea and vomiting, ocular infection and inflammation, osteoporosis, post operative management, pregnancy and lacation, probiotic and gut health, psoriasis, respiratory tract infection, rheumatoid arthritis, supplements, topical antibiotics, topical muscle relaxant, and venous disease.MINAPHARM Pharmaceuticals was founded in 1958 and is headquartered in Cairo, Egypt.
Data as of 10 Sept 2026, 21:08 (Cairo time). Source: Egyptian Exchange via TradingView; financial statements via Yahoo Finance. Prices refresh every 15 minutes during EGX trading hours (Sun–Thu).